EP0173710A1 - Systeme d'amor age pour une unite d'ultrafiltration. - Google Patents
Systeme d'amor age pour une unite d'ultrafiltration.Info
- Publication number
- EP0173710A1 EP0173710A1 EP85901153A EP85901153A EP0173710A1 EP 0173710 A1 EP0173710 A1 EP 0173710A1 EP 85901153 A EP85901153 A EP 85901153A EP 85901153 A EP85901153 A EP 85901153A EP 0173710 A1 EP0173710 A1 EP 0173710A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- blood
- ultrafiltrate
- port
- compartment
- outlet port
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3643—Priming, rinsing before or after use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3643—Priming, rinsing before or after use
- A61M1/3644—Mode of operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/366—General characteristics of the apparatus related to heating or cooling by liquid heat exchangers
Definitions
- the present invention concerns a novel system for priming an ultrafiltration unit.
- Dialyzers may require the rinsing of both the blood compartment and the dialysate compartment to prepare the dialyzer and to guard against the possibility of a hypersensitivity reaction in the patient. Of course the rinsing solution must be discarded.
- the present invention is particularly applicable to any type of ultrafiltration unit, including a hemoconcentrator, a dialyzer, a diafilter, etc.
- ultrafiltration units generaEy include an ultrafiltration membrane which separates a blood compartment from an ultrafiltrate compartment.
- the dialysate compartment of the dialyzer becomes the ultrafiltrate compart ⁇ ment.
- It is an object of the present invention to provide a system for priming an ultrafiltration unit without requiring a pump in the blood line. Another object of the present invention is to provide a system for priming an ultrafiltration unit with a provision for automatically discarding the priming solution without disconnection or reconnection of the blood set.
- a further object of the present invention is to provide a system for priming an ultrafiltration unit, enabling the priming and rinsing of both the blood compartment and the ultrafiltrate compartment, at prescribed flow and volume rates and with an automatic discard of the priming and rinsing solution without disconnection or reconnection of the blood set.
- a system for priming an ultrafiltration unit, connected to a blood source, without requiring a pump in the blood line.
- the system includes an ultrafiltration unit having an ultrafiltration membrane which separates a blood compartment from an ultrafiltrate compartment, a blood inlet port, a blood outlet port, a second inlet port communicating with the ultrafiltrate compartment, and an ultrafiltrate outlet port.
- a feedback tube connects the blood outlet port to the second inlet port, whereby a low pressure can be applied to the ultrafiltrate outlet port and priming solution introduced at the blood inlet port will be drawn through the ultrafiltration unit blood compartment as well as across the membrane and then through the ultrafiltrate compartment and out the ultrafiltrate outlet port.
- blood inlet tubing is provided for connecting the blood inlet port to a blood source.
- a first port is provided on the blood inlet tubing for connecting a pressure monitor to the blood inlet tubing.
- a second port is provided on the blood inlet tubing for connecting a priming solution container to the blood inlet tubing.
- Blood outlet tubing extends from the blood outlet port. Means are provided for connecting the ultrafiltrate outlet port to a container and means connect the container to a vacuum source.
- a flow restrictor is interposed in the feedback tube to control the flow rate of the priming solution through the blood path and then into the ultrafiltrate compartment.
- a method for priming an ultrafiltration unit connected to a blood source without requiring a pump in the blood line.
- the method comprises the steps of providing an ultrafiltration unit having an ultrafiltration membrane which separates a blood compartment from an ultrafiltrate compartment, a blood inlet port, a blood outlet port, a second inlet port communicating with the ultrafiltrate compartment and an ultrafiltrate outlet port , providing a feedback tube connecting the blood outlet port to the second inlet port? introducing priming solution to the blood inlet port; and applying a low pressure to the ultrafiltrate outlet port to draw the priming solution through the blood compartment as well as across the membrane, through the ultrafiltrate compartment, and out the ultrafiltrate outlet port.
- the method includes the steps of providing tubing for connecting the blood inlet port to a blood source- connecting a priming solution container to the blood inlet tubing; and prior to introducing the priming solution to the blood inlet port, (1) clamping the tubing upstream of the blood inlet port and introducing priming solution into the tubing upstream of the clamp; and (2) then clamping the tubing downstream of the feedback tube and removing the clamp upstream of the blood inlet port.
- FIG. 1 is a schematic diagram of a system for priming an ultrafiltration unit, constructed in accordance with the principles of the present invention.
- Figure 2 is a schematic diagram of the system of Figure 1, after a first step of priming has been accomplished.
- Figure 3 is a schematic diagram of the system of Figure 1, after a second step of priming has been accomplished.
- Figure 4 is a schematic diagram of the system of Figure 1, after the system has been fuEy primed.
- an ultrafiltration unit 10 in the exemplary form of a dialyzer, is iEustrated having a blood inlet port 12, a blood outlet port 14, a second inlet port 16 and an ultrafiltrate outlet port 18.
- ports 16 and 18 would be the dialysate inlet port and the dialysate outlet port, respectively.
- Ultrafiltration unit 10 includes a suitable ultrafiltration membrane separating the blood compartment from the ultrafiltrate compartment, as is weE-known in the art.
- a blood inlet tube 20 connects blood inlet port 12 to the outlet 22 of an oxygenator 24.
- a blood outlet tube 26 connects the blood outlet port 14 to the inlet 28 of oxygenator 24. This connection could be directly to the oxygenator iEustrated or through a cardiotomy reservoir. AdditionaEy, blood might be introduced into a blood bag or other container directly from the hemoconcentrator. The iEustrated method is for explanation only and not to restrict the choice of blood inlet source or outlet final destination.
- Blood inlet tube 20 includes a first port 30 for enabEng the connection of a pressure monitor 32 to the blood inlet tube 20.
- the blood inlet tube 20 also has a second port 34 for enabling the connection of a priming solution container 36 ( Figures 2-4) or rinsing solution container to the blood inlet tube 20.
- a feedback tube 38 having a flow restrictor 40 is connected from blood outlet port 14 to the second inlet port 16.
- the second inlet port 16 communicates with the ultrafiltrate compartment of unit 10.
- the flow restrictor 40 operates to control the flow rate through the ultrafiltration unit 10 as wiE be explained below.
- a priming solution output tube 42 connects ultrafiltrate outlet port 18 to a container 44 with the outlet 46 of container 44 being coupled to a vacuum source via tubing 48. Often the hospital has a waE vacuum which is connected to tubing 48. The operation of the system wiU now be explained. Referring to
- blood inlet tubing 20 is clamped at point 50 and a container 36 of priming solution such as saline solution, is attached to port 34.
- the portion of tubing 20 between point 50 and the oxygenator is then primed.
- the clamp is removed at point 50, the blood inlet tubing is clamped at point 52 (upstream of port 34) and the blood outlet tubing 26 is clamped at point 54 (downstream of the feedback tube 38).
- a vacuum of determined level such as 500 mm mercury is applied at ultrafiltrate outlet port l ⁇ .
- the priming fluid wiE be drawn from container 36 through the blood compartment of ultrafiltration unit 10, to point 54, through flow restrictor 40, into the ultrafiltrate compartment via second inlet port 16, out of ultrafiltrate outlet port 18 and to drain via tube 48. It can be seen that flow restrictor 40 controls the flow rate of the fluid into the ultrafiltrate compartment.
- the ultrafEtration unit 10 As the priming fluid flows through the blood compartment of ultrafEtration unit 10, some of it wiE be ultrafiltered through the membrane. The ultrafiltration unit wiE be rinsed, flushed and primed with the solution automaticaEy discarded to drain. After about five minutes, in the iEustrative embodiment, approximately 800 to 900 ml of priming solution wiE have passed through the ultrafEtration unit 10.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58385484A | 1984-02-27 | 1984-02-27 | |
US583854 | 1984-02-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0173710A1 true EP0173710A1 (fr) | 1986-03-12 |
EP0173710A4 EP0173710A4 (fr) | 1987-10-27 |
EP0173710B1 EP0173710B1 (fr) | 1990-05-02 |
Family
ID=24334860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP85901153A Expired - Lifetime EP0173710B1 (fr) | 1984-02-27 | 1985-01-25 | Systeme d'amor age pour une unite d'ultrafiltration |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0173710B1 (fr) |
JP (1) | JPS61501249A (fr) |
CA (1) | CA1256386A (fr) |
DE (1) | DE3577401D1 (fr) |
IT (1) | IT1183417B (fr) |
WO (1) | WO1985003879A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2624375B1 (fr) * | 1987-12-11 | 1997-03-28 | Hospal Ind | Procede et dispositif de rincage et d'amorcage d'un echangeur |
US5041215A (en) * | 1989-11-22 | 1991-08-20 | Cobe Laboratories, Inc. | Dialysis unit priming |
US5910252A (en) * | 1993-02-12 | 1999-06-08 | Cobe Laboratories, Inc. | Technique for extracorporeal treatment of blood |
US7744553B2 (en) | 2003-12-16 | 2010-06-29 | Baxter International Inc. | Medical fluid therapy flow control systems and methods |
US9869512B1 (en) * | 2016-11-18 | 2018-01-16 | Omnis Thermal Technologies, Llc | Pulse combustion variable residence time drying system |
ES2884853T3 (es) | 2019-08-19 | 2021-12-13 | Gambro Lundia Ab | Método de cebado de un circuito de sangre extracorpóreo de un aparato para el tratamiento de sangre extracorpóreo y aparato para el tratamiento de sangre extracorpóreo |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962075A (en) * | 1973-09-10 | 1976-06-08 | Tri-Flo Research Laboratories, Ltd. | Hemo dialyzer employing two dialysate solutions |
FR2295777A1 (fr) * | 1974-12-23 | 1976-07-23 | Alfa Laval Ab | Procede de filtration |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3907504A (en) * | 1973-04-06 | 1975-09-23 | Gen Electric | Blood oxygenation system including automatic means for stabilizing the flow rate of blood therethrough |
US3927980A (en) * | 1973-08-22 | 1975-12-23 | Baxter Laboratories Inc | Oxygen overpressure protection system for membrane-type blood oxygenators |
US4299705A (en) * | 1979-09-07 | 1981-11-10 | Russell Richard T | Method of treating blood during operative procedures |
-
1985
- 1985-01-25 DE DE8585901153T patent/DE3577401D1/de not_active Expired - Lifetime
- 1985-01-25 JP JP60500821A patent/JPS61501249A/ja active Pending
- 1985-01-25 EP EP85901153A patent/EP0173710B1/fr not_active Expired - Lifetime
- 1985-01-25 WO PCT/US1985/000124 patent/WO1985003879A1/fr active IP Right Grant
- 1985-02-25 IT IT19636/85A patent/IT1183417B/it active
- 1985-02-25 CA CA000475051A patent/CA1256386A/fr not_active Expired
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962075A (en) * | 1973-09-10 | 1976-06-08 | Tri-Flo Research Laboratories, Ltd. | Hemo dialyzer employing two dialysate solutions |
FR2295777A1 (fr) * | 1974-12-23 | 1976-07-23 | Alfa Laval Ab | Procede de filtration |
Non-Patent Citations (1)
Title |
---|
See also references of WO8503879A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE3577401D1 (de) | 1990-06-07 |
JPS61501249A (ja) | 1986-06-26 |
IT1183417B (it) | 1987-10-22 |
WO1985003879A1 (fr) | 1985-09-12 |
IT8519636A0 (it) | 1985-02-25 |
EP0173710B1 (fr) | 1990-05-02 |
EP0173710A4 (fr) | 1987-10-27 |
CA1256386A (fr) | 1989-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2091590B1 (fr) | Dispositif d'hémo(dia)filtration | |
US7588684B2 (en) | Systems and methods for handling air and/or flushing fluids in a fluid circuit | |
EP1171178B1 (fr) | Circuit extra-corporel | |
US4800022A (en) | Platelet collection system | |
EP0114698B1 (fr) | Procédé et appareil pour extraire le plasma du sang | |
EP2091591B1 (fr) | Unité de circuit pour fluide médical | |
US4670152A (en) | Priming system for ultrafiltration unit | |
US9095664B2 (en) | Method and system for providing priming and restitution liquids for an extracorporeal blood treatment | |
US20040219060A1 (en) | Device and methods for processing blood in extracorporeal circulation | |
EP0173710A1 (fr) | Systeme d'amor age pour une unite d'ultrafiltration. | |
EP2091592B1 (fr) | Enceinte extracorporelle pour le sang | |
Vertrees et al. | A technique of hemoconcentration | |
CN118022088A (zh) | 一种透析机自动预充系统 | |
JPS60135066A (ja) | ドナ−フエレシスシステム | |
JPH01280467A (ja) | 血漿採取ユニット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19851016 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE DE FR GB SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19871027 |
|
17Q | First examination report despatched |
Effective date: 19880831 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAXTER INTERNATIONAL INC. (A DELAWARE CORPORATION) |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): BE DE FR GB SE |
|
REF | Corresponds to: |
Ref document number: 3577401 Country of ref document: DE Date of ref document: 19900607 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19920401 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19920406 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19920407 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19920414 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19920522 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19930125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19930126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Effective date: 19930131 |
|
BERE | Be: lapsed |
Owner name: BAXTER INTERNATIONAL INC. (A DELAWARE CORP.) Effective date: 19930131 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19930125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19930930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19931001 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
EUG | Se: european patent has lapsed |
Ref document number: 85901153.8 Effective date: 19930810 |